Cajeta, Rowena M.
HRN: 18-45-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
CEFUROXIME 500MG (TAB)
12/18/2022
12/25/2022
PO
500
BID
Empiric Tx
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes